Get the Stockscreener App
1.45
1.36%
-0.02
After Hours:
1.41
-0.04
-2.76%
Painreform Ltd stock is traded at $1.45, with a volume of 253.27K.
It is down -1.36% in the last 24 hours and down -0.68% over the past month.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
See More
Previous Close:
$1.47
Open:
$1.46
24h Volume:
253.27K
Relative Volume:
0.09
Market Cap:
$2.92M
Revenue:
-
Net Income/Loss:
$-9.34M
P/E Ratio:
-0.2031
EPS:
-7.14
Net Cash Flow:
$-6.69M
1W Performance:
-14.20%
1M Performance:
-0.68%
6M Performance:
-53.23%
1Y Performance:
-74.05%
1-Day Range:
$1.40
$1.52
1-Week Range:
$1.40
$1.92
52-Week Range:
$1.25
$16.63
Painreform Ltd Stock (PRFX) Company Profile
Compare PRFX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRFX
Painreform Ltd
|
1.45 | 2.96M | 0 | -9.34M | -6.69M | -7.14 |
|
ZTS
Zoetis Inc
|
156.40 | 68.60B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.99 | 47.28B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.80 | 43.41B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.38 | 20.69B | 16.70B | -157.13M | 1.19B | -0.155 |
|
NBIX
Neurocrine Biosciences Inc
|
139.60 | 13.78B | 2.41B | 305.80M | 492.20M | 2.95 |
Painreform Ltd Stock (PRFX) Latest News
How cyclical is PainReform Ltd.’s revenue stream getLinesFromResByArray error: size == 0 - thegnnews.com
Identifying reversal signals in PainReform Ltd.Dip Buying & Free Fast Gain Swing Trade Alerts - Newser
Is PainReform Ltd. stock entering bullish territory2025 Market Sentiment & Daily Market Momentum Tracking - Newser
PainReform Ltd. stock retracement – recovery analysis2025 Technical Overview & Free Risk Controlled Daily Trade Plans - Newser
Smart tools for monitoring PainReform Ltd.’s price actionMarket Trend Summary & High Accuracy Swing Trade Signals - Newser
What’s next for PainReform Ltd. stock priceGold Moves & Precise Entry and Exit Recommendations - Newser
Statistical indicators supporting PainReform Ltd.’s strengthWeekly Profit Recap & Free Long-Term Investment Growth Plans - Newser
Measuring PainReform Ltd.’s beta against major indicesWeekly Trend Report & AI Forecasted Stock Moves - Newser
Key metrics from PainReform Ltd.’s quarterly dataJuly 2025 PostEarnings & Weekly Market Pulse Alerts - Newser
What technical models suggest about PainReform Ltd.’s comebackEarnings Miss & Community Verified Trade Signals - Newser
Will PainReform Ltd. stock go up soonTrade Signal Summary & Expert Verified Stock Movement Alerts - Newser
How institutional ownership impacts PainReform Ltd. stockTrade Volume Report & High Conviction Trade Alerts - Newser
Chart based exit strategy for PainReform Ltd.Earnings Recap Report & Daily Oversold Stock Bounce Ideas - Newser
Will PainReform Ltd. price bounce be sustainableWeekly Investment Summary & Low Risk High Reward Trade Ideas - Newser
Is PainReform Ltd. trending in predictive chart modelsTrade Exit Summary & Stepwise Trade Signal Implementation - Newser
Update Recap: What are PainReform Ltd.’s recent SEC filings showingJuly 2025 Trends & Weekly Watchlist for Consistent Profits - sundaytimes.kr
Strategies to average down on PainReform Ltd.2025 Price Action Summary & Smart Investment Allocation Tips - Newser
Is PainReform Ltd. stock overvalued or fairly pricedWeekly Profit Recap & Scalable Portfolio Growth Ideas - kpenews.com
What machine learning models say about PainReform Ltd.Entry Point & Expert Curated Trade Setup Alerts - Newser
Key resistance and support levels for PainReform Ltd.July 2025 Sector Moves & Real-Time Market Sentiment Alerts - Newser
Short interest data insights for PainReform Ltd.Long Setup & Consistent Return Strategy Ideas - Newser
Using Python tools to backtest PainReform Ltd. strategies2025 Price Targets & Free Long-Term Investment Growth Plans - Newser
Top chart patterns to watch in PainReform Ltd.July 2025 EndofMonth & Safe Capital Growth Tips - Newser
Painreform Ltd Stock (PRFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.14%
0.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):